NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Orchestra

Orchestra

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://orchestra.bio/

Last Round

Debt

Apr 1, 2026

Total Funding Raised

$20M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Orchestra is a business/productivity software company that has developed a life sciences R&D management platform designed to optimize the planning, execution, and monitoring of complex drug development programs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug developmentagentic operationsbiotech softwareCRO managementclinical trial managementAI drug discoverycontract analysisworkflow automationbiotech R&DAI agentsSOW analysisbiotech opspharma techAI copilotvibe coding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orchestra Comps

Public and private peers based on sector, stage, and business model.

Orchestra comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Orchestra Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtApr 1, 2026
SeedAug 4, 2025

Key People

Founding team and executive leadership

Ashoka Rajendra

CEO

Executive Team

Andy Xu

Chief Technology Officer

Executive Team

Orchestra Investors

Notable investors and investment history

Orchestra investors
InvestorRounds
Andreessen HorowitzSeed
HaystackSeed
Definition CapitalSeed
8VCSeed
MedtronicDebt
Insight PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    $20M debt round completed.

  • Aug 1, 2025

    $20M raised with participation from Andreessen Horowitz and 8VC.

Orchestra Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orchestra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orchestra's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range19
Year Founded2022
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.